Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
49,339,300
-
Share change
-
-2,337,105
-
Total reported value
-
$24,669,763
-
Price per share
-
$0.50
-
Number of holders
-
40
-
Value change
-
-$1,795,549
-
Number of buys
-
15
-
Number of sells
-
19
Institutional Holders of ORCHARD THERAPEUTICS PLC - ADS (ORTX) as of Q3 2022
As of 30 Sep 2022,
ORCHARD THERAPEUTICS PLC - ADS (ORTX) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,339,300 shares.
The largest 10 holders included
FMR LLC, FEDERATED HERMES, INC., CHI Advisors LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Temasek Holdings (Private) Ltd, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, Artal Group S.A., and ACADIAN ASSET MANAGEMENT LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.